UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Axonal transport deficits and neurodegenerative diseases

Nature reviews. Neuroscience, 2013-03, Vol.14 (3), p.161-176

2013

Volltextzugriff (PDF)

Exosome secretion is a key pathway for clearance of pathological TDP-43

Brain (London, England : 1878), 2016-12, Vol.139 (Pt 12), p.3187-3201

2016

Volltextzugriff (PDF)

Neurofilaments: neurobiological foundations for biomarker applications

Brain (London, England : 1878), 2020-07, Vol.143 (7), p.1975-1998

2020

Volltextzugriff (PDF)

Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival

Neuron (Cambridge, Mass.), 2013-10, Vol.80 (1), p.80-96

2013

Volltextzugriff (PDF)

Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD

Neurotherapeutics, 2021-01, Vol.18 (1), p.286-296

2021

Volltextzugriff (PDF)

Inflammation Induces TDP-43 Mislocalization and Aggregation

PloS one, 2015-10, Vol.10 (10), p.e0140248-e0140248

2015

Volltextzugriff (PDF)

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4054-4059

2013

Volltextzugriff (PDF)

Modeling of Electronic Mobilities in Halide Perovskites: Adiabatic Quantum Localization Scenario

Physical review letters, 2020-05, Vol.124 (19), p.196601-196601, Article 196601

2020

Volltextzugriff (PDF)

Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation

Journal of neurochemistry, 2007-07, Vol.102 (1), p.170-178

2007

Volltextzugriff (PDF)

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS

Journal of neurochemistry, 2010-06, Vol.113 (5), p.1188-1199

2010

Volltextzugriff (PDF)

Extracellular mutant SOD1 induces microglial-mediated motoneuron injury

Glia, 2010-01, Vol.58 (2), p.231-243

2010

Volltextzugriff (PDF)

Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia

Acta neuropathologica communications, 2019-07, Vol.7 (1), p.103-103, Article 103

2019

Volltextzugriff (PDF)

Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS

Nature neuroscience, 2010-11, Vol.13 (11), p.1396-1403

2010

Volltextzugriff (PDF)

Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease

Neuron (Cambridge, Mass.), 2006-02, Vol.49 (4), p.489-502

2006

Volltextzugriff (PDF)

Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis

Scientific reports, 2018-09, Vol.8 (1), p.14223-13, Article 14223

2018

Volltextzugriff (PDF)

From animal models to human disease: a genetic approach for personalized medicine in ALS

Acta neuropathologica communications, 2016-07, Vol.4 (1), p.70-70, Article 70

2016

Volltextzugriff (PDF)

Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD

Molecular neurodegeneration, 2021-01, Vol.16 (1), p.1-1, Article 1

2021

Volltextzugriff (PDF)

Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (7), p.2495-2500

2007

Volltextzugriff (PDF)

Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis

Molecular therapy, 2014-03, Vol.22 (3), p.498-510

2014

Volltextzugriff (PDF)

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3381-3387

2006

Volltextzugriff (PDF)

An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer

Nucleic acids research, 2017-10, Vol.45 (18), p.10436-10451

2017

Volltextzugriff (PDF)

Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5065

2023

Volltextzugriff (PDF)

Requirement of Myeloid Cells for Axon Regeneration

The Journal of neuroscience, 2008-09, Vol.28 (38), p.9363-9376

2008

Volltextzugriff (PDF)

Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation

The Journal of clinical investigation, 2013-05, Vol.123 (5), p.1964-1975

2013

Volltextzugriff (PDF)

1 – 25 von 2.034

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.731)
Mit Volltextzugriff
(1.842)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.822)
Französisch
(219)
Japanisch
(2)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(34)
Stroke
(33)
Critical Care
(30)
Journal Of Clinical Oncology
(29)
Intensive Care Medicine
(27)
Annals Of Intensive Care
(23)
The Journal Of Neuroscience
(21)
Alzheimer's & Dementia
(18)
Cheminform
(18)
The New England Journal Of Medicine
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Axonal transport deficits and neurodegenerative diseases

Exosome secretion is a key pathway for clearance of pathological TDP-43

Neurofilaments: neurobiological foundations for biomarker applications

Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival

Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD

Inflammation Induces TDP-43 Mislocalization and Aggregation

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

Modeling of Electronic Mobilities in Halide Perovskites: Adiabatic Quantum Localization Scenario

Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS

Extracellular mutant SOD1 induces microglial-mediated motoneuron injury

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia

Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS

Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease

Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis

From animal models to human disease: a genetic approach for personalized medicine in ALS

Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD

Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis

Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer

Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis

Requirement of Myeloid Cells for Axon Regeneration

Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation

Suchergebnisse filtern